PF’3944 is an ultra-long-acting fully biased GLP-1 receptor agonist (RA). It is being developed as a single agent weekly and as a monthly therapy, and in combination with various peptides including an ...

Robotaxi pioneer Waymo has raised another $16 billion to help fuel its ambition for its fleet of self-driving cars to provide ...

TARRYTOWN, N.Y., Feb. 02, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: REGN) today announced upcoming presentations from its ophthalmology portfolio and pipeline at the virtual Angiogenesis (Angiogenesis, ...

A step-by-step guide to installing the tools, creating an application, and getting up to speed with Angular components, ...

Experts details PeckBirdy, a JavaScript C2 framework used since 2023 by China-aligned attackers to spread malware via fake ...

GLP-1 (glucagon-like peptide-1 receptor agonists) like Ozempic and Wegovy continue to make headlines as more research points to the benefits of taking these medications. Traditionally, patients ...

Mounjaro (tirzepatide) is prescribed to manage blood sugar levels in people with type 2 diabetes. It’s available as a single-dose prefilled pen. You will administer your Mounjaro injections into your ...

Electronic fuel injection revolutionized the auto industry in the 1980s. It came to replace the carburetor in the task of sending fuel to the engine's cylinders but it does much more: it controls ...

Even as OpenAI works to harden its Atlas AI browser against cyberattacks, the company admits that prompt injections, a type of attack that manipulates AI agents to follow malicious instructions often ...

A potential JavaScript injection vulnerability exists in the Health Analytics tab of the OPD Visit page. Investigation names are interpolated directly into JavaScript string literals without proper ...

Details have emerged about a now-patched security flaw in the DeepSeek artificial intelligence (AI) chatbot that, if successfully exploited, could permit a bad actor to take control of a victim's ...

For children — and many adults — the fear of injections remains a major barrier to vaccination. But research led by Elodie Segura, PhD, from the Immunity and Cancer Laboratory at the Institut Curie in ...